Seminars in Hematology
Volume 43 , Pages S3-S10 , July 2006

Treatment of Immune Thrombocytopenic Purpura in Adults

  • James Bussel

      Affiliations

    • Corresponding Author InformationAddress correspondence to James Bussel, MD, Weil Cornell Medical Center, 525 E 68th St, Payson 695, New York, NY 10021.

References 

  1. McMillan R . Therapy for adults with refractory chronic immune thrombocytopenic purpura . Ann Intern Med . 1997;126:307–314
  2. Frederiksen H , Schmidt K . The incidence of idiopathic thrombocytopenic purpura in adults increases with age . Blood . 1999;94:909–913
  3. Neylon AJ , Saunders PWG , Howard MR , Proctor SJ , Taylor PRA  Northern Regional Haematology Group . Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults (A prospective study of a population-based cohort of 245 patients) . Br J Haematol . 2003;122:966–974
  4. British Committee for Standards in Haematology and General Haematology Task Force . Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy . Br J Haematol . 2003;120:574–596
  5. Cines DB , Bussel JB . How I treat idiopathic thrombocytopenic purpura (ITP) . Blood . 2005;106:2244–2251
  6. Cines DB , McMillan R . Management of adult idiopathic thrombocytopenic purpura . Annu Rev Med . 2005;56:425–442
  7. Cohen YC , Djulbegovic B , Shamai-Lubovitz O , Mozes B . The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts . Arch Intern Med . 2001;160:1630–1638
  8. Cortelazzo S , Finazzi G , Buelli M , Molteni A , Viero P , Barbui T . High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura . Blood . 1991;77:31–33
  9. Butros LJ , Bussel JB . Intracranial hemorrhage in immune thrombocytopenic purpura (A retrospective analysis) . J Pediatr Hematol Oncol . 2003;25:660–664
  10. Cines DB , Bussel JB , McMillan RB , Zehnder JL . Congenital and acquired thrombocytopenia . Hematology (Am Soc Hematol Educ Program) . 2004;390–406
  11. George JN , Woolf SH , Raskob GE , Wasser JS , Aledort LM , Ballem PJ , et al.   Idiopathic thrombocytopenic purpura (A practice guideline developed by explicit methods for the American Society of Hematology) . Blood . 1996;88:3–40
  12. Newman GC , Novoa MV , Fodero EM , Lesser ML , Woloski BMR , Bussel JB . A dose of 75 μg/kg/d of IV anti-D increases the platelet count more rapidly and for a longer period of time than does 50 g/kg/d in adults with immune thrombocytopenic purpura (ITP) . Br J Haematol . 2001;112:1076–1078
  13. George JN , Raskob GE , Vesely SK , Moore D , Lyons RM , Cobos E , et al.   Initial management of immune thrombocytopenic purpura in adults (A randomized controlled trial comparing intermittent anti-D with routine care) . Am J Hematol . 2003;74:161–169
  14. Bussel JB , Graziano JN , Kimberly RP , Pahwa S , Aledort LM . Intravenous anti-D treatment of immune thrombocytopenic purpura (Analysis of efficacy, toxicity, and mechanism of effect) . Blood . 1991;77:1884–1893
  15. Cooper N , Heddle NM , Haas M , Reid ME , Lesser ML , Fleit HB , et al.   Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms (Modulation of cytokine and platelet responses to IV anti-D by FcγRIIa and FcγRIIIa polymorphisms) . Br J Haematol . 2004;124:511–518
  16. Samuelsson A , Towers TL , Ravetch JV . Anti-inflammatory activity of IVIg mediated through the inhibitory Fc receptor . Science . 2001;291:484–486
  17. Andersen JC . Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy . N Engl J Med . 1994;330:1560–1564
  18. Cheng Y , Wong RSM , Soo YOY , Chui CH , Lau FY , Chan NP , et al.   Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone . N Engl J Med . 2003;349:831–836
  19. Cooper N, Woloski BM, Fodero EM, Novoa M, Leber M, Beer JH, et al. Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy? . Blood . 2002;99:1922–1927
  20. Grillo-López AJ , Hedrick C , Rashford M , Benyunes M . Rituximab (Ongoing and future clinical development) . Semin Oncol . 2002;29:105–112
  21. Cooper N , Stasi R , Cunningham-Rundles S , Feuerstein MA , Leonard JP , Amadori S , et al.   The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenia purpura . Br J Haematol . 2004;125:232–239
  22. Bennett CM , Rogers ZR , Kinnamon DD , Bussel JB , Mahoney DH , Abshire TC , et al.   Prospective phase I/II study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura . Blood . 2005;107:2639–2642
  23. Wang J , Wiley JM , Luddy R , Greenberg J , Feuerstein MA , Bussel JB . Chronic immune thrombocytopenic purpura in children (assessment of rituximab treatment) . J Pediatr . 2005;146:217–221
  24. Hasan AN , Bussel JB . Re-treatment with rituximab in ITP (comparison of standard dose with 2 forms of augmented rituximab) . Blood . 2005;106:1237; (abstr)
  25. Stasi R , Stipa E , Masi M , Cecconi M , Scimo MT , Oliva F , et al.   Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura . Am J Med . 1995;98:436–442
  26. Kojouri K , Vesely SK , Terrell DR , George JN . Splenectomy for adult patients with idiopathic thrombocytopenic purpura (A systematic review to assess long-term platelet count responses, prediction of response, and surgical complications) . Blood . 2004;104:2623–2634
  27. Schwartz J , Eldor A , Gillis S , Guinta A , Leber M , Bussel JB . Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP) . Am J Hematol . 2003;72:94–98
  28. Recommendations of the Advisory Committee on Immunization Practices (ACIP) (Use of vaccines and immune globulins in persons with altered immunocompetence) . MMWR Morb Mortal Wkly Rep . 1993;42:1–11
  29. Wasserstrom HA , Cunningham-Rundles C , Lim LCL , Guerro NT , Wissert MH , Radigan L , et al.   Splenectomized patients have reduced CD27+ memory B cells but protective antibody responses to pneumococcal vaccination . Blood . 2004;104:3025; (abstr)
  30. Fabris F , Tassan T , Ramon R , Carraro G , Randi ML , Luzzatto G , et al.   Age as the major predictor of long-term response to splenectomy in immune thrombocytopenic purpura . Br J Haematol . 2001;112:637–640
  31. Marcaccio MJ . Laparoscopic splenectomy in chronic idiopathic thrombocytopenic purpura . Semin Hematol . 2000;37:267–274
  32. Cines DB , Blanchette V . Idiopathic thrombocytopenic purpura . N Engl J Med . 2002;364:995–1008
  33. Vesely SK , Perdue JJ , Rizvi MA , Terrell DR , George JN . Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy . Ann Intern Med . 2004;140:112–120
  34. Levy AS , Cunningham-Rundles S , Mazza B , Simm M , Gorlick R , Bussel J . High P-glycoprotein-mediated export observed in patients with a history of idiopathic thrombocytopenic purpura . Br J Haematol . 2002;118:836–838
  35. Kappers-Klunne MC , van’t Veer MB . Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenia purpura refractory to corticosteroids or splenectomy . Br J Haematol . 2001;114:121–125
  36. Godeau B , Durand J-M , Roudot-Thoraval F , Tenneze A , Oksenhendler E , Kaplanski G , et al.   Dapsone for chronic autoimmune thrombocytopenic purpura (A report of 66 cases) . Br J Haematol . 1997;97:336–339
  37. Scaradavou A , Woo B , Woloski BMR , Cunningham-Rundles S , Ettinger LJ , Aledort LM , et al.   Intravenous anti-D treatment of immune thrombocytopenic purpura (Experience in 272 patients) . Blood . 1997;89:2689–2700
  38. Hou P , Pang J , Shi Y , Zhang C , Qin P , Zhao C , et al.   Mycophenolate mofetil (MMF) for the treatment of steroid-resistant idiopathic thrombocytopenic purpura . Eur J Haematol . 2003;70:353–357
  39. Figueroa M , Gehlsen J , Hammond D , Ondreyco S , Piro L , Pomeroy T , et al.   Combination chemotherapy in refractory immune thrombocytopenic purpura . N Engl J Med . 1993;328:1226–1229
  40. Huhn RD , Fogarty PF , Nakamura R , Read EJ , Leitman SF , Rick ME , et al.   High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia . Blood . 2003;101:71–77
  41. Kuter D , Bussel JB , Aledort LM , et al.   A phase 2 placebo controlled study evaluating the platelet response and safety of weekly dosing with a novel thrombopoietic protein (AMG531) in thrombocytopenic adult patients (pts) with immune thrombocytopenic purpura (ITP) . Blood . 2004;114(suppl 1):148a; (abstr)
  42. Newland A , Caulier MT , Schipperus MR , et al.   An open-label, unit dose-finding study evaluating the safety and platelet response of a novel thrombopoietic protein (AMG531) in thrombocytopenic adult patients (pts) with immune thrombocytopenic purpura (ITP) . Blood . 2004;104(suppl 1):567a; (abstr)
  43. Bussel JB, George JN, Kuter DJ, Wasser JS, Aledort LM, Chen M-G, et al. An open-label, dose-finding cohort study evaluating the safety of and platelet response to a novel thrombopoietic protein (AMG531) in thrombocytopenic patients with immune thrombocytopenic purpura (ITP) . Blood . 2003;102:86a; (abstr)
  44. Bussel JB , Mukherjee R , Stone AJ . A pilot study of rhuIL-11 treatment of refractory ITP . Am J Hematol . 2001;66:172–177
  45. Snyder HW , Cochran SK , Balint JP , Bertram JH , Mittelman A , Guthrie TH , et al.   Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura . Blood . 1992;79:2237–2245
  46. Blanchette VS , Price V . Childhood chronic immune thrombocytopenic purpura (Unresolved issues) . J Pediatr Hematol Oncol . 2003;25(suppl 1):S28–S33
  47. Caulier MT , Rose C , Roussel MT , Huart C , Bauters F , Fenaux P . Pulsed high-dose dexamethasone in refractory chronic idiopathic thrombocytopenic purpura (A report on 10 cases) . Br J Haematol . 1995;91:477–479
  48. Kuwana M , Kawakami Y , Ikeda Y . Suppression of autoreactive T-cell response to glycoprotein IIb/IIIa by blockade of CD40/CD154 interaction (Implications for treatment of immune thrombocytopenic purpura) . Blood . 2003;101:621–623
  49. Lim SH , Hale G , Marcus RE , Waldmann H , Baglin TP . CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura . Br J Haematol . 1993;84:542–544
  50. Emilia G , Longo G , Luppi M , Gandini G , Morselli M , Ferrara L , et al.   Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura . Blood . 2001;97:812–814
  51. Kohda K , Kuga T , Kogawa K , Kanisawa Y , Koike K , Kuroiwa G , et al.   Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura . Br J Haematol . 2002;118:584–588
  52. Michel M , Cooper N , Jean C , Frissora C , Bussel JB . Does Helicobacter pylori initiate or perpetuate immune thrombocytopenic purpura? . Blood . 2003;103:890–896
  53. Gill KK , Kelton JG . Management of idiopathic thrombocytopenic purpura in pregnancy . Semin Hematol . 2000;37:275–289
  54. Fujimura K , Harada Y , Fujimoto T , Kuramoto A , Ikeda Y , Akatsuka J , et al.   Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates . Int J Hematol . 2002;75:426–433
  55. Samuels P , Bussel JB , Braitman LE , Tomaski A , Druzin ML , Mennuti MT , et al.   Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura . N Engl J Med . 1990;323:229–235
  56. Michel M , Novoa MV , Bussel JB . Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy . Br J Haematol . 2003;123:142–146

PII: S0037-1963(06)00091-6

doi: 10.1053/j.seminhematol.2006.04.009

Seminars in Hematology
Volume 43 , Pages S3-S10 , July 2006

Article Tools

* Image Usage & Resolution